Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Oncology 49

Oncology

lung-cancer-symptoms-risk-factors-and-treatment-options

Snippets - A Small piece of News or Article

Lung Cancer and its Increasing Global Burden

Lung cancer possesses a significant global health burden and is one of the most common cancers. Worldwide, every year around 2 million new cases, and approximately 1.76 million deaths occur due to Lung cancer. To raise awareness about risk factors, signs and symptoms, and the importance of early detection of lung cancer, every year, the entire month of November is observed as Lung cancer awareness month. Lung Cancer And Its Types Lung cancer is a type of cancer that begins in the lungs and spreads to lymph nodes or other organs in the body, such as the brain. Based on the different microscopic appearances, lung cancer is of two types, namely small cell lun...

Explore More...

Default Blog Image

Pancreatic Cancer Market Insights, Epidemiology and Market Forecast-2020

Default Blog Image

Non-Hodgkin’s Lymphoma (NHL) – Market Insights, Epidemiology and Market Forecast-2020

Default Blog Image

Acute Myeloid Leukemia: Market Dynamics, Epidemiology, and Future Projections

Default Blog Image

Antibody-Drug Conjugate Market Insight

Default Blog Image

PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016

Default Blog Image

LAG-3 Antagonists, TIM-3 Antagonists; OX40 Agonists- Pipeline Insights, 2016 – A DelveInsight Report

Default Blog Image

Chimeric Antigen Receptor T cell Immunotherapy Market Analysis and Forecast

Default Blog Image

Zemplar Drug Insights, 2016

Default Blog Image

Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016

Default Blog Image

Pancreatic Cancer-Pipeline Insights, 2016

Default Blog Image

Peripheral Lung Cancer Pipeline Insights, 2016

Default Blog Image

Small interfering RNA (siRNA) Therapeutics

Default Blog Image

“Endometrial Cancer – Pipeline Insights, 2015”- A DelveInsight’s Report

Default Blog Image

PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2015 – A DelveInsight Report

Default Blog Image

Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015

Default Blog Image

Oral Mucositis Pipeline Insights, 2015- A DelveInsight Report

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly